Nivolumab plus Ipilimumab in Advanced Melanoma. Reply
N Engl J Med
.
2025 Mar 27;392(12):1246.
doi: 10.1056/NEJMc2501311.
Authors
Jedd D Wolchok
1
,
F Stephen Hodi
2
,
James Larkin
3
Affiliations
1
Sandra and Edward Meyer Cancer Center, New York.
2
Dana-Farber Cancer Institute, Boston.
3
Royal Marsden Hospital, London.
PMID:
40138568
DOI:
10.1056/NEJMc2501311
No abstract available
Publication types
Letter
Comment